Purple Biotech
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -48 | -48 | ||
EBITDA | -108 | -2,342 | -3,716 | |
EBIT | -157 | -2,391 | -3,764 | |
Net Income | -663 | -2,405 | -3,762 | -3,762 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,295 | -3,904 | -5,082 | -4,967 |
Cash | 5,438 | 6,524 | 9,985 | 9,985 |
Basic Shares | 346,512 | 276,628 | 266,090 | 259,399 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $-910 | $-320 | $1,000 |
Gross Profit | -196 | -1,111 | -551 | 765 |
EBITDA | -22,225 | -21,492 | -17,516 | -28,410 |
EBIT | -22,424 | -21,693 | -17,747 | -28,645 |
Net Income | -19,880 | -20,825 | -18,463 | -12,405 |
Net Change In Cash | 0 | -910 | -320 | 1,000 |
Free Cash Flow | -19,229 | -16,963 | -15,186 | -12,248 |
Cash | 14,489 | 15,030 | 10,890 | 11,247 |
Basic Shares | 221,332 | 184,815 | 178,001 | 172,106 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $1.36 |
2024-06-30 | -$0.08 |
2024-03-31 | -$0.14 |
2023-12-31 | -$0.19 |
